330 related articles for article (PubMed ID: 33941236)
21. Identification of coding and non-coding mutational hotspots in cancer genomes.
Piraino SW; Furney SJ
BMC Genomics; 2017 Jan; 18(1):17. PubMed ID: 28056774
[TBL] [Abstract][Full Text] [Related]
22. Deep Learning of Sequence Patterns for CCCTC-Binding Factor-Mediated Chromatin Loop Formation.
Kuang S; Wang L
J Comput Biol; 2021 Feb; 28(2):133-145. PubMed ID: 33232622
[No Abstract] [Full Text] [Related]
23. Chromatin accessibility of primary human cancers ties regional mutational processes and signatures with tissues of origin.
Ocsenas O; Reimand J
PLoS Comput Biol; 2022 Aug; 18(8):e1010393. PubMed ID: 35947558
[TBL] [Abstract][Full Text] [Related]
24. CTCF sites display cell cycle-dependent dynamics in factor binding and nucleosome positioning.
Oomen ME; Hansen AS; Liu Y; Darzacq X; Dekker J
Genome Res; 2019 Feb; 29(2):236-249. PubMed ID: 30655336
[TBL] [Abstract][Full Text] [Related]
25. Genomic Space of
Ibrahim Al-Obaide MA; Arutla V; Bacolod MD; Wang W; Zhang R; Srivenugopal KS
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33801310
[TBL] [Abstract][Full Text] [Related]
26. Transcription of angiogenin and ribonuclease 4 is regulated by RNA polymerase III elements and a CCCTC binding factor (CTCF)-dependent intragenic chromatin loop.
Sheng J; Luo C; Jiang Y; Hinds PW; Xu Z; Hu GF
J Biol Chem; 2014 May; 289(18):12520-34. PubMed ID: 24659782
[TBL] [Abstract][Full Text] [Related]
27. Local Determinants of the Mutational Landscape of the Human Genome.
Gonzalez-Perez A; Sabarinathan R; Lopez-Bigas N
Cell; 2019 Mar; 177(1):101-114. PubMed ID: 30901533
[TBL] [Abstract][Full Text] [Related]
28. Characterization of constitutive CTCF/cohesin loci: a possible role in establishing topological domains in mammalian genomes.
Li Y; Huang W; Niu L; Umbach DM; Covo S; Li L
BMC Genomics; 2013 Aug; 14():553. PubMed ID: 23945083
[TBL] [Abstract][Full Text] [Related]
29. Dynamic CTCF binding directly mediates interactions among cis-regulatory elements essential for hematopoiesis.
Qi Q; Cheng L; Tang X; He Y; Li Y; Yee T; Shrestha D; Feng R; Xu P; Zhou X; Pruett-Miller S; Hardison RC; Weiss MJ; Cheng Y
Blood; 2021 Mar; 137(10):1327-1339. PubMed ID: 33512425
[TBL] [Abstract][Full Text] [Related]
30. Association of mutation signature effectuating processes with mutation hotspots in driver genes and non-coding regions.
Wong JKL; Aichmüller C; Schulze M; Hlevnjak M; Elgaafary S; Lichter P; Zapatka M
Nat Commun; 2022 Jan; 13(1):178. PubMed ID: 35013316
[TBL] [Abstract][Full Text] [Related]
31. Characteristics of functional enrichment and gene expression level of human putative transcriptional target genes.
Osato N
BMC Genomics; 2018 Jan; 19(Suppl 1):957. PubMed ID: 29363429
[TBL] [Abstract][Full Text] [Related]
32. Integrative characterization of G-Quadruplexes in the three-dimensional chromatin structure.
Hou Y; Li F; Zhang R; Li S; Liu H; Qin ZS; Sun X
Epigenetics; 2019 Sep; 14(9):894-911. PubMed ID: 31177910
[TBL] [Abstract][Full Text] [Related]
33. Regional mutational signature activities in cancer genomes.
Timmons C; Morris Q; Harrigan CF
PLoS Comput Biol; 2022 Dec; 18(12):e1010733. PubMed ID: 36469539
[TBL] [Abstract][Full Text] [Related]
34. The effect of CTCF binding sites destruction by CRISPR/Cas9 on transcription of metallothionein gene family in liver hepatocellular carcinoma.
Gong W; Liu Y; Qu H; Liu A; Sun P; Wang X
Biochem Biophys Res Commun; 2019 Mar; 510(4):530-538. PubMed ID: 30738580
[TBL] [Abstract][Full Text] [Related]
35. Extensive evolutionary changes in regulatory element activity during human origins are associated with altered gene expression and positive selection.
Shibata Y; Sheffield NC; Fedrigo O; Babbitt CC; Wortham M; Tewari AK; London D; Song L; Lee BK; Iyer VR; Parker SC; Margulies EH; Wray GA; Furey TS; Crawford GE
PLoS Genet; 2012 Jun; 8(6):e1002789. PubMed ID: 22761590
[TBL] [Abstract][Full Text] [Related]
36. Genome-wide identification of regulatory DNA elements and protein-binding footprints using signatures of open chromatin in Arabidopsis.
Zhang W; Zhang T; Wu Y; Jiang J
Plant Cell; 2012 Jul; 24(7):2719-31. PubMed ID: 22773751
[TBL] [Abstract][Full Text] [Related]
37. Analysis of 7,815 cancer exomes reveals associations between mutational processes and somatic driver mutations.
Poulos RC; Wong YT; Ryan R; Pang H; Wong JWH
PLoS Genet; 2018 Nov; 14(11):e1007779. PubMed ID: 30412573
[TBL] [Abstract][Full Text] [Related]
38. Open chromatin defined by DNaseI and FAIRE identifies regulatory elements that shape cell-type identity.
Song L; Zhang Z; Grasfeder LL; Boyle AP; Giresi PG; Lee BK; Sheffield NC; Gräf S; Huss M; Keefe D; Liu Z; London D; McDaniell RM; Shibata Y; Showers KA; Simon JM; Vales T; Wang T; Winter D; Zhang Z; Clarke ND; Birney E; Iyer VR; Crawford GE; Lieb JD; Furey TS
Genome Res; 2011 Oct; 21(10):1757-67. PubMed ID: 21750106
[TBL] [Abstract][Full Text] [Related]
39. Differential DNA repair underlies mutation hotspots at active promoters in cancer genomes.
Perera D; Poulos RC; Shah A; Beck D; Pimanda JE; Wong JW
Nature; 2016 Apr; 532(7598):259-63. PubMed ID: 27075100
[TBL] [Abstract][Full Text] [Related]
40. CTCF loss mediates unique DNA hypermethylation landscapes in human cancers.
Damaschke NA; Gawdzik J; Avilla M; Yang B; Svaren J; Roopra A; Luo JH; Yu YP; Keles S; Jarrard DF
Clin Epigenetics; 2020 Jun; 12(1):80. PubMed ID: 32503656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
